Trials / Completed
CompletedNCT01534533
Effects of Lutein Supplementation on Subclinical Atherosclerosis
The Effects of Lutein Supplementation on Subclinical Atherosclerosis
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 192 (actual)
- Sponsor
- Peking University · Academic / Other
- Sex
- All
- Age
- 45 Years – 68 Years
- Healthy volunteers
- Accepted
Summary
This study is to investigate the possible positive effects of lutein and lycopene supplementation on early atherosclerosis in Beijing.
Detailed description
Atherosclerosis is the primary cause of cardiovascular and cerebrovascular diseases, both of which are the top two causes of death in industrialized countries including China. Lutein was found to be protective against atherosclerosis in some case control studies. However, the intervention on atherosclerosis have not been reported. In the present study, 192 subjects were randomly assigned to four groups treated with different amounts of lutein. The investigators observe the changes of serum lutein concentration by hyper-pressure liquid chromatography (HPLC), and compare the differences of common carotid IMT and arterial stiffness by carotid ultrasonography before and after the intervention. Serum biochemistry indexes including cholesterol (CHO), triglyceride (TG), high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C) and glucose (Glu) were measured at 0, 7 and 12 months of treatment by auto-analyzer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | one gelatine capsule containing starch per day, for 12 months |
| DIETARY_SUPPLEMENT | Lutein group | one gelatine capsule containing 20mg lutein per day, for 12 months |
| DIETARY_SUPPLEMENT | Combination group | one gelatine capsule containing 20mg lutein and 20 mg lycopene per day, for 12 months |
| DIETARY_SUPPLEMENT | Normal lutein control group | subjects without early atherosclerosis, treated with one gelatine capsule containing 20mg lutein per day, for 12 months |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2011-06-01
- Completion
- 2012-06-01
- First posted
- 2012-02-16
- Last updated
- 2013-07-22
- Results posted
- 2012-10-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01534533. Inclusion in this directory is not an endorsement.